DRUG_ID,DRUG_NAME,PUTATIVE_TARGET,PATHWAY_NAME,DRUG_SYNONYMS,SMILES,HGCN_TARGETS
1003,Camptothecin,TOP1,DNA replication,"Camptothecine, (+)-Camptothecin",CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,TOP1
1004,Vinblastine,Microtubule destabiliser,Mitosis,Velban,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,TUBB
1005,Cisplatin,DNA crosslinker,DNA replication,"cis-Diammineplatinum(II) dichloride, Platinol, CIS-DDP",N.N.Cl[Pt]Cl,DNA
1006,Cytarabine,Antimetabolite,Other,"Ara-Cytidine, Arabinosyl Cytosine, U-19920",C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,DNA synthesis
1007,Docetaxel,Microtubule stabiliser,Mitosis,"RP-56976, Taxotere",CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,TUBB
1008,Methotrexate,Antimetabolite,DNA replication,"Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR
1009,Tretinoin,Retinoic acid,Other,"ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,"RARA,RARB,RARG"
1010,Gefitinib,EGFR,EGFR signaling,"ZD-1839, Iressa",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR
1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,"ABT-263, ABT263, ABT 263",CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,"BCL2,BCL2L1,BCL2L2"
1012,Vorinostat,"HDAC inhibitor Class I, IIa, IIb, IV",Chromatin histone acetylation,"Zolinza, SAHA, suberanilohydroxamic acid, suberoylanilide hydroxamic acid, MK-0683",C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"HDAC1,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC7,HDAC8,HDAC9,HDAC10"
1013,Nilotinib,ABL,ABL signaling,"Tasigna, AMN 107",CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABL1
1014,Refametinib,"MEK1, MEK2",ERK MAPK signaling,"RDEA119, BAY-86-9766, BAY 869766",COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F,"MAP2K1,MAP2K2"
1016,Temsirolimus,MTOR,PI3K/MTOR signaling,"CCI-779, Torisel",C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,MTOR
1017,Olaparib,"PARP1, PARP2",Genome integrity,"AZD2281, KU0059436,  Lynparza",C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,"PARP1,PARP2"
1018,Veliparib,"PARP1, PARP2",Genome integrity,"ABT-888, ABT888, ABT 888",C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"PARP1,PARP2"
1019,Bosutinib,"SRC, ABL, TEC","Other, kinases","SKI-606, Bosulif",CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"SRC,ABL1,TEC"
1020,Lenalidomide,CRBN,Protein stability and degradation,"CDC-501, CC-5013, Revlimid",C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,CRBN
1021,Axitinib,"PDGFR, KIT, VEGFR",RTK signaling,"AG-13736, Inlyta",CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,"PDGFRA,KIT,FLT1,KDR,FLT4"
1022,AZD7762,"CHEK1, CHEK2",Cell cycle,"AZD-7762, AZD 7762",C1C[C@@H](CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,"CHEK1,CHEK2"
1023,GW441756,NTRK1,RTK signaling,GW 441756,CN1C=C(C2=CC=CC=C21)/C=C\3/C4=C(C=CC=N4)NC3=O,NTRK1
1024,Lestaurtinib,"FLT3, JAK2, NTRK1, NTRK2, NTRK3","Other, kinases","CEP-701, SP-924, SPM-924, A-154475, KT-555",C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,"FLT3,JAK2,NTRK1,NTRK2,NTRK3"
1025,SB216763,"GSK3A, GSK3B",WNT signaling,"SB-216763, SB 216763",CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl,"GSK3A,GSK3B"
1026,Tanespimycin,HSP90,Protein stability and degradation,"17-AAG, BMS-722782",C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,HSP90AA1
1029,Motesanib,"VEGFR, RET, KIT, PDGFR",RTK signaling,"AMG-706, AMG 706, AMG706",CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,"KDR,RET,KIT,PDGFRL"
1030,KU-55933,ATM,Genome integrity,KU55933,C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4,ATM
1031,Elesclomol,HSP90,Protein stability and degradation,STA-4783,CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2,HSP90AA1
1032,Afatinib,"EGFR, ERBB2",EGFR signaling,"BIBW2992, Tovok, Gilotrif",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,"EGFR,ERBB2"
1033,Vismodegib,SMO,Other,"GDC0449, Erivedge",CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,SMO
1034,Staurosporine,Broad spectrum kinase inhibitor,RTK signaling,-,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC,RTK
1036,PLX-4720,BRAF,ERK MAPK signaling,"PLX4720, PLX 4720",CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F,BRAF
1037,BX795,"TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC","Other, kinases",BX-795,C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I,"TBK1,PDPK1,IKBKB,AURKB,AURKC"
1038,NU7441,DNAPK,Genome integrity,"KU-57788, NU-7432, NU-7741",C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56,PRKDC
1039,SL0101,"RSK, AURKB, PIM1, PIM3","Other, kinases","SL-0101, SL 0101-1",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C,"RPS6KA1,AURKB,PIM1,PIM3"
1042,Doramapimod,"p38, JNK2",JNK and p38 signaling,"BIRB-796, BIRB 796",CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,"MAPK14,MAPK9"
1043,JNK Inhibitor VIII,JNK,JNK and p38 signaling,-,CCOC1=C(C(=CC(=N1)NC(=O)CC2=C(C=CC(=C2)OC)OC)N)C#N,"MAPK8,MAPK9,MAPK10"
1046,Wee1 Inhibitor,"WEE1, CHEK1",Cell cycle,"681640, Wee1 Inhibitor",C1=CC=C(C(=C1)C2=CC3=C(C4=C(N3)C=CC(=C4)O)C5=C2C(=O)NC5=O)Cl,"WEE1,CHEK1"
1047,Nutlin-3a (-),MDM2,p53 pathway,-,CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl,MDM2
1048,Mirin,MRE11,Genome integrity,-,C1=CC(=CC=C1/C=C\2/C(=O)NC(=N)S2)O,MRE11
1049,PD173074,"FGFR1, FGFR2, FGFR3",RTK signaling,"PD-173074, PD 173074",CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C,"FGFR1,FGFR2,FGFR3"
1050,ZM447439,"AURKA, AURKB",Mitosis,"ZM-447439, ZM 447439",COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5,"AURKA,AURKB"
1051,Alisertib,AURKA,Mitosis,MLN8237,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,AURKA
1052,RO-3306,CDK1,Cell cycle,-,C1=CC2=C(C=CC(=C2)/C=C\3/C(=O)NC(=NCC4=CC=CS4)S3)N=C1,CDK1
1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,"MK 2206, MK2206",C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,"AKT1,AKT2"
1054,Palbociclib,"CDK4, CDK6",Cell cycle,"PD0332991, PD-0332991, PF-00080665-73",CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"CDK4,CDK6"
1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,"NVP-BEZ235, BEZ235",CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,"PIK3CA,MTOR"
1058,Pictilisib,PI3K (class 1),PI3K/MTOR signaling,"GDC-0941, GDC0941, RG-7621",CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,"PIK3CA,MTOR"
1059,AZD8055,"MTORC1, MTORC2",PI3K/MTOR signaling,AZD-8055,C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C,MTOR
1060,PD0325901,"MEK1, MEK2",ERK MAPK signaling,"PD-0325901, PD 0325901",C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O,"MAP2K1,MAP2K2"
1061,SB590885,BRAF,ERK MAPK signaling,SB-590885,CN(C)CCOC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC5=C(C=C4)/C(=N/O)/CC5,BRAF
1062,Selumetinib,"MEK1, MEK2",ERK MAPK signaling,"AZD6244, AZD-6244, ARRY-886",CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,"MAP2K1,MAP2K2"
1067,CCT007093,PPM1D,Cell cycle,-,C1/C(=C\C2=CC=CS2)/C(=O)/C(=C/C3=CC=CS3)/C1,PPM1D
1068,Obatoclax Mesylate,"BCL2, BCL-XL, BCL-W, MCL1",Apoptosis regulation,"GX15-070MS, Obatoclax, GX15-070",CC1=CC(=C(N1)/C=C\2/C(=C/C(=C/3\C=C4C=CC=CC4=N3)/N2)OC)C.CS(=O)(=O)O,"BCL2,BCL2L1,BCL2L2,MCL1"
1069,EHT-1864,"RAC1, RAC2, RAC3",Cytoskeleton,EHT 1864,C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl,"RAC1,RAC2,RAC3"
1072,Avagacestat,"Amyloid beta20, Amyloid beta40",Other,"BMS-708163, BMS 708163",C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl,APP
1073,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,5-FU,C1=C(C(=O)NC(=O)N1)F,"TYMS,DPYD"
1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases","BMS-354825-03, BMS-354825, Sprycel",CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,"ABL1,SRC,EPHA1,PDGFRA,KIT"
1080,Paclitaxel,Microtubule stabiliser,Mitosis,"BMS-181339-01, Taxol, Onxol, Paxene, Praxel, Abraxane",CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,TUBB
1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,"Xalkori, PF2341066, PF-2341066, PF 2341066",C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"MET,ALK,ROS1"
1084,Rapamycin,MTORC1,PI3K/MTOR signaling,"AY-22989, Sirolimus, WY-090217, Torisel, Rapamune",C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,MTOR
1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases","Nexavar, 284461-73-0, BAY 43-9006",CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,"PDGFRA,KIT,VEGFA,RAF1"
1086,BI-2536,"PLK1, PLK2, PLK3",Cell cycle,-,CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,"PLK1,PLK2,PLK3"
1088,Irinotecan,TOP1,DNA replication,"Camptosar, (+)-Irinotecan, Irinotecanum, irinotecan hydrochloride",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,TOP1
1089,Oxaliplatin,DNA alkylating agent,DNA replication,Eloxatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],DNA
1091,BMS-536924,"IGF1R, IR",IGF1R signaling,BMS 536924,CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5,"IGF1R,INSR"
1093,GSK1904529A,"IGF1R, IR",IGF1R signaling,"GSK-1904529A, GSK 1904529A",CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F,"IGF1R,IR"
1096,Tozasertib,"AURKA, AURKB, AURKC, others",Mitosis,"MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68",CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,"AURKA,AURKB,AURKC"
1129,PF-4708671,S6K1,PI3K/MTOR signaling,"PF 4708671, PF4708671",CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F,RPS6KB1
1131,PRIMA-1MET,TP53 activation,p53 pathway,"Prima 1MET, APR-246",COCC1(C(=O)C2CCN1CC2)CO,TP53
1133,Serdemetan,MDM2,p53 pathway,JNJ-26854165,C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4,MDM2
1149,TW 37,"BCL2, BCL-XL, MCL1",Apoptosis regulation,"TW37, TW-37",CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C,"BCL2,BCL2L1,MCL1"
1168,Erlotinib,EGFR,EGFR signaling,"Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,EGFR
1170,CCT-018159,HSP90,Protein stability and degradation,"CCT018159, CCT 018159",CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C,HSP90AA1
1175,Rucaparib,"PARP1, PARP2",Genome integrity,"PF-01367338, AG-014699, AG-14447, AG-14699",CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,"PARP1,PARP2"
1177,Niraparib,"PARP1, PARP2",Genome integrity,"MK-4827, MK4827",C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,"PARP1,PARP2"
1179,MK-1775,"WEE1, PLK1",Cell cycle,"AZD1775, Adavosertib",CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,"WEE1,PLK1"
1180,Dinaciclib,"CDK1, CDK2, CDK5, CDK9",Cell cycle,"SCH727965, SCH 727965, SCH-727-965, MK-7965",CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO,"CDK1,CDK2,CDK5,CDK9"
1190,Gemcitabine,Pyrimidine antimetabolite,DNA replication,"Gemzar, LY-188011",C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,"RRM1,RRM2"
1191,Bortezomib,Proteasome,Protein stability and degradation,"PS-341, LDP-341, Velcade",B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PSMB5
1192,GSK269962A,"ROCK1, ROCK2",Cytoskeleton,GSK 269962A,CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6,"ROCK1,ROCK2"
1194,SB505124,"TGFBR1, ACVR1B, ACVR1C",RTK signaling,"SB 505124, SB505124",CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4,"TGFBR1,ACVR1B,ACVR1C"
1199,Tamoxifen,ESR1,Hormone-related,"Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar",CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ESR1
1200,Fulvestrant,ESR,Hormone-related,"Faslodex, ICI-182780",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,"ESR1,ESR2"
1237,EPZ004777,DOT1L,Chromatin histone methylation,EPZ-004777,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O,DOT1L
1239,YK-4-279,RNA helicase A,Other,YK 4-279,COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O,DHX9
1243,Piperlongumine,Induces reactive oxygen species,Other,Piplartine,COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCC=CC2=O,ROS1
1248,Daporinad,NAMPT,Metabolism,"APO866,  FK866, FK866",C1CN(CCC1CCCCNC(=O)/C=C/C2=CN=CC=C2)C(=O)C3=CC=CC=C3,NAMPT
1249,BMS-345541,"IKK-1, IKK-2",Other,-,CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN,"IKBKB,CHUK"
1250,AZ960,"JAK2, JAK3","Other, kinases","AZ 960, AZ-960",CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F,"JAK2,JAK3"
1259,Talazoparib,"PARP1, PARP2",Genome integrity,"BMN-673, BMN 973",CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,"PARP1,PARP2"
1268,XAV939,"TNKS1, TNKS2",WNT signaling,"NVP-XAV939, XAV-939, XAV 939",C1CSCC2=C1N=C(NC2=O)C3=CC=C(C=C3)C(F)(F)F,"TNKS,TNKS2"
1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,"GSK1120212, Mekinist",CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,"MAP2K1,MAP2K2"
1373,Dabrafenib,BRAF,ERK MAPK signaling,"GSK2118436, Tafinlar",CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,BRAF
1375,Temozolomide,DNA alkylating agent,DNA replication,"Temodar, Temodal, M-39831, SCH 52365",CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,DNA
1378,Bleomycin (50 uM),dsDNA break induction,DNA replication,-,,dsDNA
1401,AZD5438,CDK2,Cell cycle,SN1057898678,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C,CDK2
1428,IAP_5620,IAP,Other,SN1043546339,,"BIRC2,BIRC3,XIAP,BIRC5,BIRC6,BIRC7,None"
1441,AZD2014,"mTORC1, mTORC2",PI3K/MTOR signaling,SN1103949359,C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOC[C@@H]5C,"MTOR,MTOR"
1449,AZD1208,"PIM1, PIM2, PIM3","Other, kinases",SN1028350371,C1C[C@H](CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)/C=C\4/C(=O)NC(=O)S4)N,"PIM1,PIM2,PIM3"
1463,AZD1332,"NTRK1, NTRK2, NTRK3",RTK signaling,SN1061387896,CC(C)OC1=NNC(=C1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=C3)F,"NTRK1,NTRK2,NTRK3"
1494,SN-38,TOP1,DNA replication,"7-Ethyl-10-Hydroxy-Camptothecin, SN 38",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,TOP1
1502,Bicalutamide,AR,Hormone-related,"ICI-176334, Casodex, Cosudex, ICI 176334",CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,AR
1507,Ruxolitinib,"JAK1, JAK2","Other, kinases","INCB-18424, Ruxolitinib Phosphate, Jakafi",C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,"JAK1,JAK2"
1510,Linsitinib,IGF1R,IGF1R signaling,"OSI-906, ASP-7487",CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,IGF1R
1511,Epirubicin,Anthracycline,DNA replication,"Ellence, Farmorubicin, IMI-28",C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,"TOP2A,TOP2B"
1512,Cyclophosphamide,Alkylating agent,DNA replication,"Cytoxan, Neosar, Cyclophosphamid, Procytox, Cyclophosphane",C1CNP(=O)(OC1)N(CCCl)CCCl,DNA
1529,Pevonedistat,NAE,Other,"MLN4924, MLN 4924, MLN-4924",C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N,NAE1
1549,Sapitinib,"EGFR, ERBB2, ERBB3",EGFR signaling,AZD8931,CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC,"EGFR,ERBB2,ERBB3"
1553,Uprosertib,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,"GSK2141795, GSK2141795C, GSK-2141795",CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl,"AKT1,AKT2,AKT3"
1557,LCL161,"XIAP, IAP1, IAP2",Apoptosis regulation,-,C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC,"XIAP,BIRC2,BIRC3"
1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,"Tykerb, Tyverb",CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,"EGFR,ERBB2"
1559,Luminespib,HSP90,Protein stability and degradation,"AUY922, VER-52296,NVP-AUY922,  AUY",CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C,"HSP90AA1,HSP90AB1"
1560,Alpelisib,PI3Kalpha,PI3K/MTOR signaling,"BYL719, BYL-719, NVP-BYL719",CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PIK3CA
1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,"GDC-0032, GDC0032, RG7604",CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,"PIK3CA,PIK3CB,PIK3CD,MTOR"
1563,EPZ5676,DOT1L,Chromatin histone methylation,"EPZ-5676, Pinometostat",CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C,DOT1L
1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,CS-1421,C1CN(C[C@@H]1C(=O)NC2=CC3=C(C=C2)NN=C3C4=CC=NC=C4)CC(=O)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7,"MAPK3,GPSM2"
1576,IWP-2,PORCN,WNT signaling,Wnt Inhibitor IWP-2,CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC4=C(C(=O)N3C5=CC=CC=C5)SCC4,PORCN
1578,Leflunomide,Pyrimidine synthesis inhibitor,DNA replication,"Sulol, SU-101, HWA-486, Arava",CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,DHODH
1580,GSK2801,,Chromatin other,"1-(7-(2-methylsulfonyl-phenyl)-4-propoxy-1-aza-bicyclo[4.3.0]nona-2,4,6,8-tetraen-9-yl)-ethanone",CCCOC1=CC2=C(C=C(N2C=C1)C(=O)C)C3=CC=CC=C3S(=O)(=O)C,"BRD9,BRD7"
1581,Bromosporine,"CECR2, BRD2, BRD4, BRD9",Chromatin other,"ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate",CCOC(=O)NC1=CC(=NN2C1=NN=C2C)C3=CC(=C(C=C3)C)NS(=O)(=O)C,"CECR2,BRD2,BRD4,BRD9"
1582,SGC-CBP30,"EP300, CBP",Chromatin histone acetylation,"8-(3-chloro-4-methoxy-phenethyl)-4-(3,5-dimethyl-isoxazol-4-yl)-9-(2-(morpholin-4-yl)-propyl)-7,9-diaza-bicyclo[4.3.0]nona-1(6),2,4,7-tetraene",CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)C[C@H](C)N5CCOCC5,"EP300,CREBBP"
1583,GSK-LSD1,KDM1,Chromatin histone methylation,"N-((1R,2S)-2-phenylcyclopropyl)piperidin-4-amine",C1CNCCC1N[C@@H]2C[C@H]2C3=CC=CC=C3,KDM1A
1584,BDOCA000347a,"BRPF1, BRPF2, BRPF3",Chromatin histone acetylation,"4-bromo-N-(6-methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methylbenzenesulfonamide",,"BRPF1,BRD1,BRPF3"
1585,BDF00022089a,"BRPF1, BRPF2, BRPF3",Chromatin histone acetylation,-,,"BRPF1,BRD1,BRPF3"
1586,BDILV000379a,"BAZ2A, BAZ2B",Chromatin histone acetylation,"4-(4-(1-methyl-1H-pyrazol-4-yl)-1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-4,5-dihydro-1H-imidazol-5-yl)benzonitrile",,"BAZ2A,BAZ2B"
1593,Entinostat,"HDAC1, HDAC3",Chromatin histone acetylation,MS-275,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,"HDAC1,HDAC3"
1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,A-1065-5,COC1=CC=CC2=C1NC(=C2)C3=C4C(=NC=NN4C(=N3)C5CCC(CC5)C(=O)O)N,"MTOR,MTOR"
1598,LGK974,PORCN,WNT signaling,LGK-974,CC1=CC(=CN=C1C2=CC(=NC=C2)C)CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4,PORCN
1613,VE-822,ATR,Genome integrity,"VE 822, VE822, Berzosertib",CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,ATR
1614,WZ4003,"NUAK1, NUAK2","Other, kinases",WZ 4003,CCC(=O)NC1=CC(=CC=C1)OC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC,"NUAK1,NUAK2"
1615,CZC24832,PI3Kgamma,PI3K/MTOR signaling,GTPL6653,CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F,PIK3CG
1617,AZD5582,"XIAP, cIAP",Apoptosis regulation,"GTPL7710, AOB5560",C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)OCC#CC#CCO[C@@H]5CC6=CC=CC=C6[C@@H]5NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)NC,"XIAP,BIRC2,BIRC3"
1618,GSK2606414,PERK,Metabolism,AK175551,CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F,EIF2AK3
1620,PFI3,"Polybromo 1, SMARCA4, SMARCA2",Chromatin other,"PFI-3, PFI 3, AOB2221",C1[C@@H]2CN([C@H]1CN2C3=CC=CC=N3)/C=C/C(=O)C4=CC=CC=C4O,"PBRM1,SMARCA4,SMARCA2"
1621,PCI-34051,"HDAC8, HDAC6, HDAC1",Chromatin histone acetylation,AK298746,COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO,"HDAC8,HDAC6,HDAC1"
1622,Wnt-C59,PORCN,WNT signaling,"AOB3540, AK161197",CC1=NC=CC(=C1)C2=CC=C(C=C2)CC(=O)NC3=CC=C(C=C3)C4=CN=CC=C4,PORCN
1624,I-BET-762,"BRD2, BRD3, BRD4",Chromatin other,GSK525762A,CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,"BRD2,BRD3,BRD4"
1625,RVX-208,BRD4,Chromatin other,"1044870-39-4, Apabetalone",CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2,BRD4
1626,OTX015,"BRD2, BRD3, BRD4",Chromatin other,"Birabresib, OTX-015, MK-8628",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,"BRD2,BRD3,BRD4"
1627,GSK343,EZH2,Chromatin histone methylation,"GTPL8240, AOB3680, AK175558",CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC(=NC=C4)N5CCN(CC5)C)C(C)C,EZH2
1629,ML323,"USP1, UAF1",Protein stability and degradation,"GTPL7898, AOB2313,",CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C,"USP1,WDR48"
1630,Entospletinib,SYK,"Other, kinases",GS-9973,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,SYK
1631,PRT062607,SYK,"Other, kinases","P505-15, PRT-2607, BIIB-057",C1CC[C@H]([C@H](C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N,SYK
1632,Ribociclib,"CDK4, CDK6",Cell cycle,"LEE011, NVP-LEE011, LEE011-BBA",CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,"CDK4,CDK6"
1634,AGI-6780,IDH2 R140Q mutant,Metabolism,AK162157,C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F,IDH2
1635,Picolinici-acid,Inflammatory related,Other,Picolinate,,Inflammatory related
1706,AZD5153,BRD4,Chromatin other,"SN1045566955, AZD5153",C[C@@H]1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C,BRD4
1708,CDK9_5576,CDK9,Cell cycle,"SN1047226266, CDK9_5576",,CDK9
1709,CDK9_5038,CDK9,Cell cycle,"SN1047483750, CDK9_5038",,CDK9
1712,Eg5_9814,KSP11,Other,"SN1047613775, Eg5_9814",,KIF11
1713,ERK_2440,"ERK1,ERK2",ERK MAPK signaling,"SN1051032892, ERK_2440",,"MAPK3,GPSM2"
1714,ERK_6604,"ERK1,ERK2",ERK MAPK signaling,"SN1047587618, ERK_6604",,"MAPK3,GPSM2"
1716,IRAK4_4710,IRAK4,"Other, kinases","SN1050852374, IRAK4_4710",,IRAK4
1718,JAK1_8709,JAK1,"Other, kinases","SN1049200060, JAK1_8709",,JAK1
1720,AZD5991,MCL1,Apoptosis regulation,"SN1049446612, AZD5991",CC1=C2C(=NN1C)CSCC3=NN(C(=C3)CSC4=CC5=CC=CC=C5C(=C4)OCCCC6=C(N(C7=C6C=CC(=C27)Cl)C)C(=O)O)C,MCL1
1730,PAK_5339,"PAK1, PAK2",Cytoskeleton,"SN1046290829, PAK_5339",,"PAK1,PAK2"
1732,TAF1_5496,TAF1,Other,"SN1050393042, TAF1_5496",,TAF1
1733,ULK1_4989,ULK1,"Other, kinases","SN1049257073, ULK1_4989",,ULK1
1734,VSP34_8731,VSP34,Other,"SN1049998399, VSP34_8731",,PIK3C3
1738,IGF1R_3801,IGFR1,IGF1R signaling,"SN1051640224, IGF1R_3801",,IGF1R
1739,JAK_8517,"JAK1, JAK2","Other, kinases","SN1066590414, JAK_8517",,"JAK1,JAK2"
1776,GSK2256098C,FAK1,Cytoskeleton,-,,PTK2
1777,GSK2276186C,"JAK1, JAK2, JAK3","Other, kinases",-,,"JAK1,JAK2,JAK3"
1778,GSK2110183B,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,-,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl.Cl,"AKT1,AKT2,AKT3"
1779,GSK626616AC,DYRK1A,"Other, kinases",-,,DYRK1A
1780,GSK3337463A,NIK,"Other, kinases",-,,MAP3K14
1782,GSK2830371A,PPM1D,Other,-,,PPM1D
1783,LMB_AB1,"ADRA1A, ADRB1",Other,-,,"ADRA1A,ADRB1"
1784,LMB_AB2,GADD34,Unclassified,-,,PPP1R15A
1785,LMB_AB3,PPP1R15B,Other,-,,PPP1R15B
1786,AZD4547,"FGFR1, FGFR2, FGFR3",RTK signaling,1035270-39-3,C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC,"FGFR1,FGFR2,FGFR3"
1799,Ibrutinib,BTK,"Other, kinases","PCI-32765, CRA-032765, PCI-32765-00",C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,BTK
1802,Zoledronate, ,Other,"Zoledronic acid, Zometa, Reclast",C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,nan
1803,Acetalax,,Unclassified,Oxyphenisatin acetate,CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C,
1808,Topotecan,TOP1,DNA replication,-,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,TOP1
1809,Teniposide,,DNA replication,Vumon,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O,MTOR
1810,Mitoxantrone,TOP2,DNA replication,-,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,"TOP2A,TOP2B"
1811,Dactinomycin,RNA polymerase,Other,Actinomycin D,C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C,LINC02397
1812,Bleomycin,dsDNA break induction,DNA replication,-,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,dsDNA
1813,Fludarabine,Antimetabolite,DNA replication,Fludara,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,DNA
1814,Nelarabine,,DNA replication,"Atriance, Arranon",COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,
1815,Dacarbazine,CP11A,Other,DTIC,CN(C)/N=N/C1=C(NC=N1)C(=O)N,CYP1A1
1817,Romidepsin,"HDAC1, HDAC2, HDAC3, HDAC8",Chromatin histone acetylation,"Istodax, FK228, Depsipeptide",C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,"HDAC1,HDAC2,HDAC3,HDAC8"
1820,123829,,Unclassified,-,,
1821,765771,,Unclassified,-,,
1824,123138,,Unclassified,-,,
1825,Podophyllotoxin bromide,,Unclassified,-,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)C(C4=CC5=C(C=C24)OCO5)Br,
1826,50869,,Unclassified,-,,
1827,Dihydrorotenone,,Unclassified,-,CC(C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC,
1828,720427,,Unclassified,-,,
1829,667880,,Unclassified,-,,
1830,Gallibiscoquinazole,,Unclassified,-,COC1=C(C(=C2C(=C1)C(=O)NC(N2)(NC(=O)OC)NC(=O)OC)OC)OC,
1831,L-Oxonoreleagnine,,Unclassified,-,C1CNC(=O)C2=C1C3=CC=CC=C3N2,
1832,729189,,Unclassified,-,,
1833,741909,,Unclassified,-,,
1834,743380,,Unclassified,-,,
1835,Elephantin,,Unclassified,-,CC(=CC(=O)O[C@H]1CC2=C[C@@H](C[C@@]3([C@H](O3)[C@@H]4[C@@H]1C(=C)C(=O)O4)C)OC2=O)C,
1836,150412,,Unclassified,-,,
1838,Sinularin,,Unclassified,-,C/C/1=C\CCC(C2CC(CCC3(C(O3)CC1)C)C(=C)C(=O)O2)(C)O,
1839,615590,,Unclassified,-,,
1840,630600,,Unclassified,-,,
1843,LMP744,TOP1,DNA replication,MJ-III-65,COC1=C(C=C2C(=C1)C3=C(C4=CC5=C(C=C4C3=O)OCO5)N(C2=O)CCCNCCO)OC,TOP1
1844,776928,,Unclassified,-,,
1845,Schweinfurthin A,,Unclassified,-,CC(=CCC/C(=C/CC1=C(C=C(C=C1O)/C=C/C2=CC3=C(C(=C2)O)O[C@@]4(C[C@H]([C@H](C([C@H]4C3)(C)C)O)O)C)O)/C)C,
1847,BEN,,Unclassified,-,,
1849,Sabutoclax,"BCL2,  BCL-XL,  BFL1, MCL1",Apoptosis regulation,BI-97C1,CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(=O)NC[C@H](C)C5=CC=CC=C5)O)O)O)O)O)O)C(=O)NC[C@H](C)C6=CC=CC=C6,"BCL2,BCL2L1,BCL2A1,MCL1"
1852,LY2109761,TGFB1,Other,5XE,C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6,None
1853,OF-1,"BRPF1B, BRPF2",Chromatin histone acetylation,-,CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C,"BRD1,BRD1"
1854,MN-64,"TNKS1, TNKS2",WNT signaling,-,CC(C)C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3O2,"TNKS,TNKS2"
1855,KRAS (G12C) Inhibitor-12,KRAS (G12C),ERK MAPK signaling,GTPL8020,,KRAS
1862,MG-132,"Proteasome, CAPN1",Protein stability and degradation,"LLL cpd, MG 132, MG132",CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1,"SMC6,CAPN1"
1866,BDP-00009066,MRCKB_HUMAN,Cytoskeleton,-,,CDC42BPA
1873,Buparlisib,"PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma",PI3K/MTOR signaling,"BKM120, NVP-BKM120",C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,"PIK3CA,PIK3CD,PIK3CB,PIK3CG"
1908,Ulixertinib,"ERK1, ERK2",ERK MAPK signaling,"BVD-523, VRT752271",CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl,"MAPK3,GPSM2"
1909,Venetoclax,BCL2,Apoptosis regulation,"ABT-199, Veneclexta, GDC-0199",CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,BCL2
1910,ABT737,"BCL2, BCL-XL,  BCL-W, BCL-B, BFL1",Apoptosis regulation,-,CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-],"BCL2,BCL2L1,BCL2L2,BCL2L10,BCL2A1"
1912,Afuresertib,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,"GSK2110183, GSK2110183C",CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl,"AKT1,AKT2,AKT3"
1913,AGI-5198,IDH1 (R132H),Metabolism,IDH-C35,CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C,IDH1
1915,AZD3759,EGFR,EGFR signaling,-,C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,EGFR
1916,AZD5363,"AKT1, AKT2, AKT3, ROCK2","Other, kinases",-,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,"AKT1,AKT2,AKT3,ROCK2"
1917,AZD6738,ATR,Genome integrity,"AZD 6738, AZD-6738",C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4,ATR
1918,AZD8186,"PI3Kalpha, PI3Kbeta",PI3K/MTOR signaling,"AZD 8186, AZD-8186",C[C@H](C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F,"PIK3CA,PIK3CB"
1919,Osimertinib,EGFR,EGFR signaling,"AZD9291, AZD 9291, AZD-9291, Tagrisso, Mereletinib",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,EGFR
1922,Cediranib,"VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB",RTK signaling,"AZD2171, AZD 2171, AZD-2171, Recentin",CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,"FLT1,KDR,FLT4,FLT3,KIT,PDGFRB"
1924,Ipatasertib,"AKT1, AKT, AKT3",PI3K/MTOR signaling,"GDC0068, GDC 0068, GDC-0068",C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,"AKT1,AKT2,AKT3"
1925,GDC0810,"ESR1, ESR2",Hormone-related,"GDC-0810, GDC 0810",CC/C(=C(/C1=CC=C(C=C1)/C=C/C(=O)O)\C2=CC3=C(C=C2)NN=C3)/C4=C(C=C(C=C4)F)Cl,"ESR1,ESR2"
1926,GNE-317,PI3Kalpha,PI3K/MTOR signaling,"GNE317, GNE 317",CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)C5(COC5)OC,PIK3CA
1927,GSK2578215A,LRRK2,"Other, kinases","GSK 2578215A,  GSK-2578215A",C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4,LRRK2
1928,I-BRD9,BRD9,Chromatin other,"GSK602, GSK 602, GSK-602",CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F,BRD9
1930,Telomerase Inhibitor IX,Telomerase,Genome integrity,"MST-312, MST 312, MST312",C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O,TERT
1931,MIRA-1,TP53,p53 pathway,"MIRA 1, MIRA1, NSC19630, NSC-19630, NSC 19630",CCC(=O)OCN1C(=O)C=CC1=O,TP53
1932,NVP-ADW742,IGF1R,IGF1R signaling,"NVP ADW742, NVPADW742",C1CCN(C1)CC2CC(C2)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC=C5)OCC6=CC=CC=C6,IGF1R
1933,P22077,"USP7, USP47",Protein stability and degradation,"P 22077, P-22077",CC(=O)C1=CC(=C(S1)SC2=C(C=C(C=C2)F)F)[N+](=O)[O-],"USP7,USP47"
1936,Savolitinib,MET,RTK signaling,"AZD6094, Volitinib, AZD-6094, AZD 6094",C[C@@H](C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,MET
1939,UMI-77,MCL1,Apoptosis regulation,"UMI 77, UMI-77",C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br,MCL1
1940,WIKI4,"TNKS1, TNKS2",WNT signaling,"WIKI-4, WIKI 4",COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6,"TNKS,TNKS2"
1941,Sepantronium bromide,BIRC5,Apoptosis regulation,"YM155, YM-155, YM 155",CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],BIRC5
1996,MIM1,MCL1,Apoptosis regulation,"MIM 1, MIM-1",CC1=CSC(=NC2CCCCC2)N1/N=C/C3=C(C(=C(C=C3)O)O)O,MCL1
1997,WEHI-539,BCL-XL,Apoptosis regulation,"WEHI539, WEHI-539",C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)/C(=N/NC5=NC6=CC=CC=C6S5)/C1,BCL2L1
1998,BPD-00008900,,Other,-,,
1999,N25720-51-A1,,Unclassified,-,,
2000,N27922-53-1,,Unclassified,-,,
2002,N30652-18-1,,Unclassified,-,,
2003,N29087-69-1,,Unclassified,-,,
2010,HKMTI-1-005,,Unclassified,-,,
2011,ICL-SIRT078,SIR2,Other,-,COC1=C(C2=CC=CC=C2C=C1)CN3C=NC4=C(C3=O)C5=C(S4)CC(CC5)NCC6=CN=CC=C6,SIRT1
2038,UNC0638,"G9A, GLP",Chromatin histone methylation,-,CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5,"EHMT2,EHMT1"
2039,AGK2,"BAZ2A, BAZ2B",Chromatin histone acetylation,-,C1=CC2=C(C=CC=N2)C(=C1)NC(=O)/C(=C/C3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)/C#N,"BAZ2A,BAZ2B"
2040,Foretinib,"MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR",RTK signaling,"GSK1363089, XL-880, EXEL-2880, GSK089",COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,"MET,KDR,TEK,FLT4,MST1R,PDGFRA,FGFR1,EGFR"
2043,BIBR-1532,TERT,Genome integrity,-,C/C(=C\C(=O)NC1=CC=CC=C1C(=O)O)/C2=CC3=CC=CC=C3C=C2,TERT
2044,Pyridostatin,G-quadruplex stabiliser,DNA replication,-,C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN,DHX36
2045,AMG-319,PI3K (beta sparing),PI3K/MTOR signaling,AMG319,C[C@@H](C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5,"PIK3CA,PIK3CB,PIK3CD,PIK3CG,MTOR"
2046,MK-8776,"CHEK1, CHEK2, CDK2",Cell cycle,SCH900776,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,"CHEK1,CHEK2,CDK2"
2048,Vinorelbine,Microtubule destabiliser,Mitosis,"vinorelbine tartrate, Navelbine, Exelbine",CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,TUBB
2055,Mycophenolic acid,,Unclassified,-,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,
2057,Remodelin,,Unclassified,-,C1CCC(=NNC2=NC(=CS2)C3=CC=C(C=C3)C#N)C1,
2096,VX-11e,ERK2,ERK MAPK signaling,"VX11e, VX11e",CC1=CN=C(N=C1C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)NC4=C(C=C(C=C4)F)Cl,GPSM2
2107,LJI308,"RSK2, RSK1, RSK3",PI3K/MTOR signaling,-,C1COCCN1C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F,"RPS6KA2,RPS6KA1,RPS6KA3"
2109,AZ6102,"TNKS1, TNKS2",WNT signaling,-,C[C@@H]1CN(C[C@@H](N1)C)C2=NC=C(C(=C2)C)C3=CC=C(C=C3)C4=NC5=C(C=CN5C)C(=O)N4,"TNKS,TNKS2"
2110,GSK591,PMRT5,Chromatin histone methylation,"EPZ015866, GSK3203591",C1CC(C1)NC2=NC=CC(=C2)C(=O)NC[C@@H](CN3CCC4=CC=CC=C4C3)O,PRMT5
2111,VE821,ATR,Genome integrity,"VE 821, VE-821",CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N,ATR
2112,VTP-A,,Unclassified,-,,
2113,VTP-B,,Unclassified,-,,
2145,PBD-288,,Unclassified,-,,
2148,POMHEX,,Unclassified,-,CC(C)(C)C(=O)OCOP(=O)(C1CCCN(C1=O)O)OCOC(=O)C(C)(C)C,
2149,CT7033-2,"KDM4A, KDM4C, KDM4E, KDM3A, KDM6B",Chromatin histone methylation,-,,"KDM4A,KDM4C,KDM4E,KDM3A,KDM6B"
2154,GSK-LSD1-2HCl ,LSD1,Chromatin histone methylation,-,,KDM1A
2156,5-azacytidine,DNA methyltransferases,Other,-,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,"DNMT1,DNMT3A,DNMT3B"
2157,A-366,"EHMT1, EHMT2",Chromatin histone methylation,-,COC1=C(C=C2C(=C1)C3(CCC3)C(=N2)N)OCCCN4CCCC4,"EHMT1,EHMT2"
2158,CPI-637,EP300,Chromatin histone methylation,-,C[C@@H]1CC(=O)NC2=CC=CC(=C2N1)C3=CC4=C(C=C3)N(N=C4C5=CN(N=C5)C)C,EP300
2159,UNC0379,SETD8,Chromatin histone methylation,-,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCCC3)NCCCCCN4CCCC4)OC,KMT5A
2169,AZD6482,PI3Kbeta,PI3K/MTOR signaling,"AZD 6482, AZD-6482, AK-55409",CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,PIK3CB
2170,AT13148,AKT1,PI3K/MTOR signaling,-,C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O,AKT1
2171,BMS-754807,"IGF1R, IR",IGF1R signaling,BMS-754807,C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,"IGF1R,INSR"
2172,JQ1,"BRD2, BRD3, BRD4, BRDT",Chromatin other,"JQ-1, (+)-JQ-1",CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C,"BRD2,BRD3,BRD4,BRDT"
2173,PFI-1,BRD4,Chromatin other,-,CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O,BRD4
2174,IOX2,EGLN1,Other,"IOX-2, IOX 2, AK176060",C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,EGLN1
2175,CHIR-99021,"GSK3A, GSK3B",WNT signaling,"CT 99021, CHIR99021, CHIR 99021",CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N,"GSK3A,GSK3B"
2177,SGC0946,DOT1L,Chromatin histone methylation,-,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O,DOT1L
2359,GSK2830371,WIP1,Other,,CC1=C(C=C(C=N1)Cl)NCC2=CC=C(S2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4,PPM1D
2360,THR-101,Mutant RAS,PI3K/MTOR signaling,WIMM synthesis,CC1=CC=CC=C1N2C(=O)C3=C(S2)C=C(C=C3)F,"HRAS,KRAS,NRAS"
2361,THR-102,Mutant RAS,PI3K/MTOR signaling,WIMM synthesis,,"HRAS,KRAS,NRAS"
2362,THR-103,Mutant RAS,PI3K/MTOR signaling,WIMM synthesis,,"HRAS,KRAS,NRAS,PIK3CA,MTOR"
2438,ascorbate (vitamin C),anti-oxidant proteins,Other,back-up solution from YWKim,,"SOD1,CAT,GPX1"
2439,glutathione,anti-oxidant proteins,Other,"G6013, sigma",C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,"GPX1,GPX4,SOD1,SOD2,CAT"
2498,alpha-lipoic acid,Metabolism,Metabolism,aLA,C1CSSC1CCCCC(=O)O,Metabolism
2499,N-acetyl cysteine,Metabolism,Metabolism,NAC,CC(=O)N[C@@H](CS)C(=O)O,Metabolism
